Biotechnology and Development ApS: Financial statements 2020
CVR: 33870639
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 79,025 and a net result of DKK 46,761 compared with DKK -8,380 the year before. That is an increase of 309.7% compared with the year before. Equity in the 2020 report amounted to DKK 58,486. The solvency ratio was 40.6%.
- Gross Profit
- DKK 79,025
- Profit/Loss
- DKK 46,761
- Equity
- DKK 58,486
- Total Assets
- DKK 144,193
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 79 t. | 47 t. | 58 t. | 0 |
| 2019 | - | 19 t. | -8 t. | 12 t. | - |
| 2018 | - | 36 t. | 6 t. | 20 t. | 1 |
| 2017 | - | 25 t. | -3 t. | 15 t. | - |
| 2016 | - | 32 t. | 13 t. | 17 t. | - |
Official annual report
How creditworthy is Biotechnology and Development ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biotechnology and Development ApS has published its annual report for 2019. Gross profit came to DKK 19,289, and the net result was DKK -8,380.
About Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.